Breaking News
NatGas Spikes As Major West Virginia Pipeline Declares Force Majeure
White House Restores Access For Banned Media Outlets After Judge's Ruling
Iran Media Reports Tehran Stance 'Unchanged' Amid US Talks At UN
This "ETFE" Dome Costs $4,200 and Resists High Heat, UVs and Weathering. Why It's Ide
Top Tech News
Tesla Model 3 killer charges from 10 to 97% in just 9 minutes
World-first unpowered DNA computer sets speed record
I Power 5 Buildings Off-Grid. Here's How
The US government is pushing hard to get a working nuclear fission reactor into space by late 2028
SpaceX Starmind AI in Space Radiator
China Will Dominate Global Nuclear Energy Through 2035, Analyst Says
These Absolutely Wild-Looking EVs Are Saudi Arabia's First Homegrown Cars
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone 
Aubrey de Grey Thinks Robust Human Longevity Might Be Here by 2037
There is fastly progressing science and there is a rapid increase in funding and formation of companies. Areas that were making slow progress like Mitosens are now rapidly progressing. Cross-linking is making progress as well.
Robust mouse rejuvenation could be only 3 years away instead of five years. Robust mouse rejuvenation could be by 2022.
Aubrey is more optimistic that partial SENS will be able to deliver significant life extension impact.
Aubrey sees a lot of activity in all seven areas of aging damage identified by SENS.
It seems that the removal of senescent cells will deliver useful health benefits and some longevity.
Aubrey indicates that SENS has a fantastic relationship with the Buck Institute. SENS has multiple projects.
Aubrey is working at AgeX as a Vice-president. Previously Aubrey had believed that there was not much need for SENS to fund stem cell research. Aubrey always considered stem cells to be important. Michael West is doing some of the most important work on stem cells.